NCT06920082

Brief Summary

With regular practice, relaxation has been found to have many benefits such as reducing sensitivity to pain and fatigue, facilitating the transition to sleep, and improving quality of life. Therefore, this study was planned to examine the effects of progressive muscle relaxation exercises applied to pancreatic and colon cancer patients receiving chemotherapy on sleep, fatigue, and pain.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable pancreatic-cancer

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable pancreatic-cancer

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 3, 2025

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 2, 2025

Completed
5 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 9, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2025

Completed
Last Updated

April 9, 2025

Status Verified

February 1, 2025

Enrollment Period

1 month

First QC Date

April 2, 2025

Last Update Submit

April 2, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Visual Analog Scale

    The patients were asked to mark their level of pain during relaxation or activities on a 10 cm vertical or horizontal line. In addition, there were forms which were numbered from 1-10 or from 1-100. The number 0 is found at the beginning of the line, and the number 10 is located at the end of the line. A value of 0 shows that there is no pain, and the value 10 expresses unendurable pain. GAS is a common scale in the assessment of pain level. A patient is asked to mark the perceived pain on this line, and the marked point is measured in cm.

    Baseline, pre-intervention (Before progressive muscle relaxation exercises applied)

  • Visual Analog Scale

    The patients were asked to mark their level of pain during relaxation or activities on a 10 cm vertical or horizontal line. In addition, there were forms which were numbered from 1-10 or from 1-100. The number 0 is found at the beginning of the line, and the number 10 is located at the end of the line. A value of 0 shows that there is no pain, and the value 10 expresses unendurable pain. GAS is a common scale in the assessment of pain level. A patient is asked to mark the perceived pain on this line, and the marked point is measured in cm.

    After the intervention (After progressive muscle relaxation exercises applied in week 6)

  • The Piper Fatigue Scale

    It is a 22-item scale that measures four subscales: behavior (6 items), affect (5 items), sensory (5 items), and cognition/mood (6 items). Each item has 11 response categories on a 0-10 metric with verbal descriptors anchoring the endpoints. Each subscale is scored individually and then aggregated together for an overall score, with higher scores reflecting more fatigue.

    Baseline, pre-intervention (Before progressive muscle relaxation exercises applied)

  • The Piper Fatigue Scale

    It is a 22-item scale that measures four subscales: behavior (6 items), affect (5 items), sensory (5 items), and cognition/mood (6 items). Each item has 11 response categories on a 0-10 metric with verbal descriptors anchoring the endpoints. Each subscale is scored individually and then aggregated together for an overall score, with higher scores reflecting more fatigue.

    After the intervention (After progressive muscle relaxation exercises applied in week 6)

Secondary Outcomes (2)

  • Pittsburgh Sleep Quality Index (PSQI)

    Baseline, pre-intervention (Before progressive muscle relaxation exercises applied)

  • Pittsburgh Sleep Quality Index (PSQI)

    After the intervention (After progressive muscle relaxation exercises applied in week 6)

Study Arms (2)

Progressive muscle relaxation exercises

EXPERIMENTAL

A total of 18 sessions of progressive relaxation were performed, 3 days a week for 6 weeks

Other: Progressive muscle relaxation exercises

Control group

NO INTERVENTION

Routine maintenance will be applied

Interventions

A total of 18 sessions of progressive relaxation were performed, 3 days a week for 6 weeks.

Progressive muscle relaxation exercises

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being over 18 years of age
  • Being able to communicate adequately
  • Not having a psychiatric problem
  • Those who are determined by a physician to have no physical obstacle to exercise
  • Individuals who can use technological devices
  • Patients who have had at least 3 cycles

You may not qualify if:

  • Those with communication problems
  • Those with psychiatric problems
  • Patients doing any exercise
  • Individuals with phones that do not have a voice recording feature
  • Individuals with phones that do not have a WhatsApp feature

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Sabahattin Zaim University, Faculty of Health Sciences

Küçükçekmece, Istanbul, 340340, Turkey (Türkiye)

Location

Related Publications (2)

  • Toraman RL, Eskici Ilgin V. Effect of Virtual Reality Glasses Application on Pain, Anxiety, and Patient Satisfaction During a Transrectal Prostate Biopsy: A Randomized Controlled Trial. Biol Res Nurs. 2024 Oct;26(4):485-497. doi: 10.1177/10998004241236154. Epub 2024 Feb 28.

  • Loh EW, Shih HF, Lin CK, Huang TW. Effect of progressive muscle relaxation on postoperative pain, fatigue, and vital signs in patients with head and neck cancers: A randomized controlled trial. Patient Educ Couns. 2022 Jul;105(7):2151-2157. doi: 10.1016/j.pec.2021.10.034. Epub 2021 Nov 3.

MeSH Terms

Conditions

Pancreatic NeoplasmsColonic Neoplasms

Condition Hierarchy (Ancestors)

Digestive System NeoplasmsNeoplasms by SiteNeoplasmsEndocrine Gland NeoplasmsDigestive System DiseasesPancreatic DiseasesEndocrine System DiseasesColorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Zülfünaz Özer, PhD

    İstanbul Sabahattin Zaim Üniversitesi

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 2, 2025

First Posted

April 9, 2025

Study Start

March 3, 2025

Primary Completion

April 7, 2025

Study Completion

July 31, 2025

Last Updated

April 9, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations